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Abstract
Cu(II) and Zn(II) complexes of N-hydroxyimidazoles were synthesised by reacting simple metal perchlorate salts with the imidazole
ligand in alcohol and formulated with a metal:ligand ratio of 1:2. The X-ray crystal structures of five complexes (four Cu(II) and one
Zn(II)) were obtained and each showed the two trans, N-hydroxyimidazole ligands forming six-membered, chelate rings with the metal.
Both of the NO chelating, neutral N-hydroxyimidazole ligands are in the zwitterion form, with the uncoordinated imidazole imine N
atom being protonated and the oxime O atom deprotonated. In the solid state the complexes form hydrogen-bonded supramolecular
structures.
 2007 Elsevier Ltd. All rights reserved.
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1. Introduction
The imidazole diazole ring is commonly found in highly
significant endogenous biomolecules, including biotin, the
essential amino acid histidine, histamine, the pilocarpine
alkaloids [1] and other alkaloids, which have been shown
to exhibit interesting biological activities such as antimicro-
bial, anticryptococcal, inhibition of nitric oxide synthase,
and cytotoxic activities [2]. Several imidazole derivatives,
such as cimetidine, etomidate and ketoconazole, are com-
monly prescribed pharmaceutical drugs [3,4]. N-hydroxy-
imidazoles have been reported [5] to possess occidiostatic,
anthelmintic, herbicidal, insecticidal, nematocidal, fungi-
cidal and bacteriostatic activities. Antihypertensive activity
was observed in some N-hydroxyimidazole-5-methanamine
derivatives [6], and N-hydroxyimidazole-3-oxides have
been investigated as reactivators of organophosphate-
inhibited acetylcholinesterase enzymes [7]. Recently [8,9],
we have described the synthesis and structures of a number
of metal complexes containing bidentate, bis-imidazole
ligands. A common structural feature of these ligands is
that the two imidazole rings are linked by a single spacer
tetrahedral carbon. In the present work, five new N-
hydroxyimidazole ligands (Fig. 1) were prepared and these
have a direct link between the two heteroxyclic rings (imid-
azole–imidazole or imidazole–pyridine). The N-hydroxyim-
idazole ligands were complexed to Cu(II) and Zn(II)
centres. Five complexes were crystallographically charac-
terised, revealing that the chelating ligands exist in a novel
zwitterion form.
2. Results and discussion
Cu(II) and Zn(II) complexes of the N-hydroxyimidaz-
oles were synthesised by reacting the simple metal perchlo-
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rate salt with the imidazole ligand in alcohol. The com-
plexes were soluble in a variety of organic solvents and
insoluble in water. The complexes formulated with a
metal:ligand ratio of 1:2 and were characterised by spec-
troscopy {IR and NMR (where appropriate)}, microanal-
ysis and X-ray crystallography.
The X-ray crystal structure of [Cu(L1)2](ClO4)2 Æ H2O
(Figs. 2a–2c, Tables 1 and 2) shows the Cu(II) ion sitting
at a centre of symmetry and with tetragonal geometry.
The two L1 ligands form six-membered, chelate rings with
the metal and are trans to each other. Both of the NO che-
lating, neutral N-hydroxyimidazole ligands have tautomer-
ised and are in the zwitterion form (Fig. 3), with the
uncoordinated imidazole imine N atom being protonated
and the oxime O atom deprotonated. There are also long
axial bonds to the two perchlorate anions and the solvate
water molecule makes three hydrogen bonds to the proton-
ated amine, the oxime O atom and to a perchlorate O
atom. The two heterocyclic rings within each ligand are
titled at 13.8(1) to one another. There is p–p stacking
(Fig. 2b) creating an infinite two-dimensional network
sheet structure. The sheets are linked through the hydrogen
bonds between the water molecules and the ligands result-
ing in the formation of channels which host the water mol-
ecules (Fig. 2c).
The three other Cu(II) complexes and one Zn(II) com-
plex all contain two NO chelating zwitterionic N-hydroxy-
imidazole ligands (Figs. 4–7, Tables 1 and 2) and have core
structures similar to [Cu(L1)2](ClO4)2 Æ H2O. The three
anhydrous Cu(II) complexes have approximate square pla-
nar coordination geometry. In the case of [Cu(L2)2](ClO4)2
there are additional hydrogen bonding interactions
between the protonated imine N atoms and the perchlorate
oxygen atoms stitching neighbouring complexes into infi-
nite chains (for example see Fig. 4). Intermolecular bridg-
ing perchlorates and p–p stacking orders the
[Cu(L3)2](ClO4)2 units complexes into a supramolecular
array (Fig. 5). In the case of [Cu(L5)2](ClO4)2, weak ‘Cu–
perchlorate–protonated imine’ interactions create chains
of complex dications (Fig. 7b).
In [Zn(L4)2MeOH](ClO4)2 Æ MeOH the cation is a cen-
trosymmetric dimer (Fig. 6a) where the two halves
(Fig. 6b) are linked by two bridging deprotonated hydroxyl
Fig. 2a. X-ray structure of [Cu(L1)2](ClO4)2 Æ H2O.
Fig. 2b. p–p stacking in [Cu(L1)2](ClO4)2 Æ H2O.
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Fig. 1. N-hydroxyimidazole ligands.
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O atoms (O2). The Zn(II) ions are six-coordinate, the
sixth ligand being a methanol solvate molecule. There is
extensive hydrogen bonding network involving the coordi-
nated methanol, the methanol of solvation, the perchlorate
anion and the hydrogen of the protonated amine N atom.
This three-dimensional coordination polymer structure is
shown in Fig. 6c.
To our knowledge, the above five complexes are the first
documented examples of N-hydroxyimidazoles tautomeris-
ing to form zwitterions upon complexation to a metal ion
and, as such, represent a novel class of ligand.
3. Experimental
Chemicals were purchased from commercial sources
and, unless specified, were used without further purifica-
tion. N-Hydroxyimidazoles were prepared by reacting
monoximes with aldehydes and ammonia [10,11]. Infrared
spectra of solids (in a KBr matrix) were recorded in the
region 4000–400 cm1 on a Nicolet FT-IR Impact 400D
infrared spectrometer. 1H NMR spectra were run as solu-
tions in DMSO-d6 on a Bruker Avance 300 MHz instru-
ment. Microanalytical data were provided by the
Microanalytical Laboratory, National University of Ire-
land, Cork, Ireland. X-ray crystallographic data (Table
3) were collected at 150 K on a Bruker SMART 1000 dif-
fractometer using Mo Ka radiation (k = 0.71073 A˚). The
structures were solved by direct methods and refined by
full-matrix least-squares on F2 using all the reflections.
All the non-hydrogen atoms were refined anisotropically
and hydrogen atoms bonded to carbon were inserted at
calculated positions using a riding model. Hydrogen
atoms bonded to O or N were located from difference
maps and refined with fixed, isotropic thermal parameters,
Table 1
Selected bond lengths (A˚) and angles ()
Complex [Cu(L1)2](ClO4)2 Æ H2O [Cu(L
2)2](ClO4)2 Æ H2O [Cu(L
3)2](ClO4)2 [Zn(L
4)2MeOH](ClO4)2 Æ MeOH [Cu(L
5)2](ClO4)2
M–O 1.9217(15) 1.9305(12) 1.9297(13) 2.0409(15), 2.0941(15) 1.9299(16)
M–N 2.0523(17) 2.0140(14) 1.9479(15) 2.0550(19), 2.0783(19) 1.9678(19)
O–M–N 90.61(7) 90.25(5) 93.14(6) 90.26(7), 87.77(7) 93.35(7)
O–M–N#1 89.39(7) 89.75(5) 86.86(6) 89.87(7), 92.67(7) 86.65(7)
Symmetry ops #1 x + 1, y + 1, z + 1 x + 2, y + 1, z x + 1, y + 1, z + 1 none x + 2, y, z + 2
Table 2
Hydrogen bonds (A˚ and )
D–H. . .A d(D–H) d(H. . .A) d(D. . .A) Æ(DHA)
[Cu(L1)2](ClO4)2 Æ H2O
N(2)–H(2N). . .O(1W) 0.84(3) 1.91(3) 2.723(3) 162(3)
O(1W)–H(1WA). . .O(11)#1 0.75(3) 2.16(3) 2.911(2) 177(3)
O(1W)–H(2WB). . .O(1)#2 0.78(3) 2.08(3) 2.831(2) 161(3)
[Cu(L2)2](ClO4)2 Æ H2O
N(2)–H(2N). . .O(11) 0.82(3) 2.01(3) 2.8284(19) 177(2)
[Cu(L3)2](ClO4)2
N(2)–H(2N). . .O(14)#3 0.79(3) 2.11(3) 2.895(2) 169(3)
N(3)–H(3N). . .O(11) 0.84(3) 2.06(3) 2.859(2) 157(3)
[Zn(L4)2MeOH](ClO4)2 Æ MeOH
N(12)–H(12). . .O(23)#4 0.88 2.02 2.831(3) 153.6
N(13)–H(13). . .O(12) 0.88 2.03 2.898(3) 169.9
N(22)–H(22). . .O(11)#5 0.88 2.02 2.894(3) 172.2
N(23)–H(23). . .O(22)#6 0.88 2.21 3.012(3) 152.1
N(23)–H(23). . .O(14)#7 0.88 2.57 3.182(3) 126.9
O(40)–H(40). . .O(50) 0.85 1.87 2.717(3) 172.6
O(50)–H(50). . .O(24) 0.85 2.23 3.032(3) 158.4
[Cu(L5)2](ClO4)2
N(2)–H(2N). . .O(11) 0.86 1.95 2.787(3) 163.1
N(3)–H(3N). . .O(12) 0.88 2.12 2.946(4) 154.7
Symmetry transformations used to generate equivalent atoms: #1 x,
y + 2, z + 1; #2 x + 1, y + 2, z + 1; #3 x  1, y + 2, z + 1;
#4 x, y, z + 1; #5 x, y + 1, z; #6 x, y + 1, z + 1; #7 x + 1,
y + 1, z + 1.
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Fig. 3. Zwitterionic form of N-hydroxyimidazole ligands chelated to the
metal (M2+) centre.
Fig. 2c. Hydrogen-bonded water molecules in the channels formed in
[Cu(L1)2](ClO4)2 Æ H2O.
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except for [Zn(L4)2MeOH](ClO4)2 Æ MeOH (where all the
H atoms were inserted at calculated positions) and
[Cu(L5)2](ClO4)2 (where they were located and not further
refined).
3.1. [Cu(L1)2](ClO4)2 Æ H2O
A solution of Cu(ClO4)2 Æ 6H2O and L
1 (1:2 mol ratio) in
acetonitrile was refluxed for 4 h and then left to stand over-
night. The precipitated green complex was recrystallised
from a mixture of acetonitrile and ethanol. Yield = 81%.
The complex was soluble in hot acetonitrile and insoluble
in water. Anal. Calc. for C20H24N6O11Cl2Cu: C, 36.46; H,
3.67; N, 12.76. Found: C, 36.50; H, 3.29; N, 12.32%. IR:
3456, 3121, 1644, 1605, 1573, 1541, 1491, 1434, 1316,
1288, 1231, 1117, 969, 928, 823, 782, 625, 484 cm1.
3.2. [Cu(L2)2](ClO4)2 Æ H2O
This green complex was prepared and recrystallised in a
similar way to [Cu(L1)2](ClO4)2 Æ H2O. Yield = 56%. The
complex was soluble in hot acetonitrile and insoluble in
water. Anal. Calc. for C40H32N6O11Cl2Cu: C, 52.97; H,
3.56; N, 9.27. Found: C, 52.92; H, 3.31; N, 9.33%. IR:
3456, 3126, 1605, 1576, 1544, 1480, 1427, 1309, 1210,
1096, 925, 825, 764, 702, 623, 545 cm1.
Fig. 4a. X-ray structure of [Cu(L2)2](ClO4)2.
Fig. 4b. Hydrogen bonding interactions forming infinite chains of [Cu(L2)2](ClO4)2 complexes.
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Fig. 5. X-ray structure of [Cu(L3)2](ClO4)2.
Fig. 6a. X-ray structure of dimeric [Zn(L4)2MeOH](ClO4)2 Æ MeOH.
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Fig. 6b. One half of dimeric [Zn(L4)2MeOH](ClO4)2 Æ MeOH.
Fig. 6c. Extensive hydrogen bonding network in [Zn(L4)2MeOH](ClO4)2 Æ MeOH.
Fig. 7a. X-ray structure of [Cu(L5)2](ClO4)2.
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3.3. [Cu(L3)2](ClO4)2
This green complex was prepared and recrystallised in a
similar way to [Cu(L1)2](ClO4)2 Æ H2O. Yield = 61%. The
complex was soluble in hot acetonitrile and insoluble in
water. Anal. Calc. for C16H20N8O10Cl2Cu: C, 31.05; H,
3.26; N, 18.11. Found: C, 31.09; H, 3.10; N, 18.34%. IR:
3227, 1619, 1512, 1439, 1292, 1234, 1097, 960, 928, 789,
760, 669, 620, 473 cm1.
3.4. [Zn(L4)2MeOH](ClO4)2 Æ MeOH
This white complex was prepared in the same manner as
[Cu(L1)2](ClO4)2 Æ H2O and was recrystallised from a
Fig. 7b. Chains of [Cu(L5)2](ClO4)2 formed through ‘Cu–perchlorate–protonated imine’ interactions.
Table 3
Crystal data and structure refinements
Complex [Cu(L1)2](ClO4)2 Æ H2O [Cu(L
2)2](ClO4)2 [Cu(L
3)2](ClO4)2 [Zn(L
4)2MeOH](ClO4)2 Æ MeOH [Cu(L
5)2](ClO4)2
Empirical formula C20H26Cl2CuN6O12 C40H30Cl2CuN6O10 C16H20Cl2CuN8O10 C38H36Cl2N8O12Zn C16H20Cl2CuN8O10
Formula weight 676.91 889.14 618.84 933.02 618.84
Crystal system triclinic monoclinic triclinic triclinic monoclinic
Space group P1 P21/n P1 P1 P21/c
a (A˚) 7.7461(10) 10.0378(8) 4.8193(5) 10.1946(7) 10.8501(9)
b (A˚) 9.0192(12) 9.8351(8) 9.9883(10) 12.9732(9) 6.9525(6)
c (A˚) 9.9153(13) 19.2452(15) 12.3209(12) 15.7194(11) 15.5483(13)
a () 71.879(2) 90 110.492(2) 97.800(1) 90
b () 84.956(2) 95.7500(10) 95.627(2) 92.308(1) 93.044(1)
c () 74.375(2) 90 93.404(2) 105.961(1) 90
Volume (A˚3) 634.03(14) 1890.4(3) 550.08(10) 1973.8(2) 1171.24(17)
Z 1 2 1 2 2
Dcalc (Mg/m) 1.773 1.562 1.868 1.570 1.755
Reflections collected 5122 15171 4690 17260 9520
Independent reflections
[Rint]
2799 [0.0176] 4386 [0.0205] 2471 [0.0124] 9032 [0.0226] 2745 [0.0185]
Data/restraints/parameter 2799/0/198 4386/0/271 2471/0/177 9032/0/552 2745/0/171
Goodness-of-fit on F2 1.024 1.031 1.073 1.022 0.896
R1, wR2 [I > 2r(I)] 0.0310, 0.0720 0.0317, 0.0787 0.0266, 0.0664 0.0390, 0.0880 0.0370, 0.1037
R1, wR2 (all data) 0.0427, 0.0773 0.0418, 0.0834 0.0308, 0.0685 0.0573, 0.0973 0.0444, 0.1094
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mixture of methanol and acetonitrile. Yield = 83%. The
complex was soluble in hot methanol and acetonitrile and
insoluble in water. Anal. Calc. for C36H28N8O10Cl2Zn: C,
49.76; H, 3.25; N, 12.89. Found: C, 49.20; H, 3.49; N,
12.76%. 1H NMR: 7.00–7.15 (aromatic H, m), 7.57–7.69
(imidazole H, m). IR: 3272, 1646, 1510, 1436, 1301, 1104,
987, 926, 760, 698, 655, 627, 529 cm1.
3.5. [Cu(L5)2](ClO4)2
This green complex was prepared and recrystallised in a
similar way to [Cu(L1)2](ClO4)2 Æ H2O. Yield = 72%. The
complex was soluble in hot acetonitrile and ethanol and
insoluble in water. Anal. Calc. for C16H20N8O10Cl2Cu: C,
31.05; H, 3.26; N, 18.11. Found: C, 30.74; H, 3.02; N,
17.52%. IR: 3217, 1609, 1531, 1443, 1317, 1126, 1039,
919, 811, 767, 713, 627, 473 cm1.
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Appendix A. Supplementary material
CCDC 638219, 638220, 638221, 638222 and 638223 con-
tain the supplementary crystallographic data for
[Cu(L1)2](ClO4)2 Æ H2O, [Cu(L
2)2](ClO4)2 Æ H2O, [Cu(L
3)2]-
(ClO4)2, [Zn(L
4)2MeOH](ClO4)2 Æ MeOH and [Cu(L
5)2]-
(ClO4)2. These data can be obtained free of charge via
http://www.ccdc.cam.ac.uk/conts/retrieving.html, or from
the Cambridge Crystallographic Data Centre, 12 Union
Road, Cambridge CB2 1EZ, UK; fax: (+44) 1223-336-
033; or e-mail: deposit@ccdc.cam.ac.uk. Supplementary
data associated with this article can be found, in the online
version, at doi:10.1016/j.poly.2007.06.034.
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